Unleashing the power of data
In the realm of oncology research, a surge of new trials is on the horizon. With a remarkable number of studies set to commence in the next three months, the landscape of cancer treatment is poised for groundbreaking advancements. The data reveals a promising trend, showcasing the dedication of researchers and the relentless pursuit of innovative therapies. As we look ahead to the coming months, the anticipation is palpable, as each trial holds the potential to transform the lives of countless patients. The field of oncology stands at the cusp of a new era, where hope and progress intersect to shape a brighter future for all those affected by cancer.
Number of Trials Conducted by AstraZeneca in China Post Covid
AstraZeneca COVID-19 Trials in China Over the Years
Breakdown of Trials by Type or Category for 2023 and 2024
Number of Trials with Device Based Interventions Started Since Jan 2024
Number of Phase III Trials in Atopic Dermatitis by Start Year
AstraZeneca Clinical Trials in China Post-COVID
Total trials in 2024
Total trials by start year
Number of Oncology Trials Initiated Since January 2024
Number of Oncology Trials Initiated Since January 2024
Number of Trials Conducted by AstraZeneca in China Post-COVID
AstraZeneca Clinical Trials in China Post-COVID